ABOUT 5th_EHTF
> AGENDA​
> REGISTRATION​
> ATTENDEES​
> INVESTORS​
> PRESENTERS​
> SPONSORS​
> SUPPORTERS​
​> NETWORKING​
> VENUE​
> ACCOMMODATION​

> ABOUT LAST YEAR​

We are pleased to announce that the 5th Annual European HealthTech CEO Forum (#Sachs_EHTF) will take place on the 27th February 2024 back at the Hilton Zurich Airport Hotel. The event will be part of the Sachs Spring Life Sciences Week, which will also incorporate the 17th Annual European Life Sciences CEO Forum.

The physical programme will consist of the usual panels and keynotes, which will be available on demand from the 6th of March. Additionally, there will be pre-arranged in-person meetings, live and on demand company showcases and a reception. During the online week, virtual meetings will be available through the audio/video online meeting system.

The 5th EHTF is a unique annual gathering of industry leaders from Europe, Asia and the USA. The main programme will feature more than 5 hours of high-level speeches and panel discussions focusing on investment & partnership in MedTech and Digital Health. In addition, there will be a global company showcase of about 20 presentations by established public, private, emerging, and seed companies, offering innovative solutions and seeking investment and partnering opportunities. This will include a limited number of live presentations taking place in dedicated presenting tracks, alongside virtual company showcases, which will be available on demand during the virtual week. We expect around 250+ delegates from 20+ countries to join us in Zurich for the networking and business opportunities. These include Digital Health, MedTech/Device companies, banks, investors and advisors with part of the audience participating virtually.

The In-Person meetings will be taking place on the 27th of February, while virtual meetings will take place on the 6th - 8th of March. For the virtual meetings, the system will allow you to have a secure audio/video call, as well as the option to present slides using a screen share function and we will have a dedicated room for in-person meetings. We expect 1800+ meetings completed during SSLSW. The conference will be held in the Central European Time Zone and the programme will consist of:

Tuesday, 27th of February

• BioPharma Reboot: Harnessing the Power of AI & Supercomputers Panel
• New Frontiers in Personalised Medicine with AI Powered Diagnostics Panel
• Digital Solutions for Chronic & Other Medical Conditions Panel
• State of the Industry: MedTech & Device Panel
• Advances in Cardiovascular Tech Panel
• Meeting the Challenges of Medtech & Device Growth Companies Panel
• Investors Roundtable
• Rising Stars – HealthTech Seed Companies Session

In-Person Meetings - 27th of February
Virtual Meetings via Online Meeting System - 6th - 8th of March
Networking Reception - 27th of February
On-Demand Content - from 6th of March

Confirmed Keynote Speakers Include:

• Jeffrey Jump, Chairman & CEO, MedAlliance SA

Confirmed Chairs & Speakers Include:

• André Hofmann, CEO, biosaxony Management GmbH
• Andreas Holm Mattsson, Founder & Chief AI & Culture Officer, Evaxion Biotech A/S
• Arnd Kaltofen, Managing Partner, VI Partners AG
• Barbara Castellano, Partner, Panakès Partners SGR SpA
• Beat Lechmann, Early Innovation Partner MedTech EMEA, Johnson & Johnson Innovation LLC
• Beat Merz, Managing Director, New Harbor Venture Partners, LLC
• Boris Bogdan, Lead HCLS EMEA, Amazon Web Services
• Carolin Barth, Partner & Director, Boston Consulting Group
• Cornelia Jahnel, Head Investor Relations, biosaxony Management GmbH
• Damien Ng, Thematic Research Analyst, Bank Julius Baer & Co. Ltd.
• Eran Toledo, CTO, Sanara Ventures
• Eric de La Fortelle, Managing Partner, Cathay Health
• Finbar Dolan, CEO, Versono Medical Ltd.
• Frank Bulens, Partner, imec.xpand
• Frank Hensel, Principal, High-Tech Gründerfonds
• Giancarlo Rizzoli, CEO, 4D Lifetec AG
• Jean-François Rivassou, Partner, Kurma Partners
• Jeffrey Jump, Chairman & CEO, MedAlliance SA
• Jonas Brambeck, Senior Investment Director, Industrifonden
• Jordi Martorell, Co-Founder & CEO, Aortyx SL
• Laurent Choppe, Managing Partner, Cukierman & Co. Life Sciences
• Lior Teitelbaum, Principal, Venture Investments, Johnson & Johnson Innovation – JJDC, Inc.
• Magdalena Plotczyk, Investment Manager, MTIP AG
• Marek Kozlowski, Senior Investment Director, NRW.Venture
• Martin Mueller, Senior Investment Manager, CARMA FUND Management GmbH
• Mateusz Sagan, SVP, Chief Operating Officer, SDS Optic Inc.
• Michalis Papadakis, Co-Founder & CEO, Brainomix Limited
• Michele Marzola, CEO, Digital Networks PLC
• Mike Karim, CEO, Oxford Endovascular Ltd.
• Miro Venturi, Healthcare Executive/ Board Member of ArchiMed & President, DIAMANTE Healthcare Consulting
• Moritz Schöllauf, Co-Founder & CEO, nyra health GmbH
  
• Oliver Harrison, Founder, Managing Director & CEO, Koa Health Limited
• Pascale Eede, Venture Developer, Apollo Health Ventures
• Philippe Menu, EVP, Chief Product Officer & Chief Medical Officer, SOPHiA GENETICS
• Rainer Metzger, Head of Integrated Clinical Services, Medicover AB
• Regina Hodits, Managing Partner, Wellington Partners
• Sebastian Alexander, CEO, VivoSensMedical GmbH
• Steve Kappenthuler, Co-Founder & CBO, MUVON Therapeutics AG
• Tanja Dowe, Managing Director, Angelini Ventures S.p.A.
• Todor Jeliaskov, Chairman & CEO, inHEART
• Tom Gibbs, Senior Investment Director, Debiopharm Innovation Fund
• Ulrich Muehlner, Co-founder & CEO, docdok.health Ltd.
• More TBA...

To view the full list of speakers in 2023, please click here.

PARTICIPATION OPTIONS:

Complimentary passes are provided for qualified institutional (buy/sell-side), private equity and venture investors. The number of passes is limited, and priority is given to regular participants, however the organiser has the discretion to reject registrations. Other participants may consider purchasing access, which includes in-person or virtual participation, with different options to showcase your company.

NETWORKING OPPORTUNITIES:

The Online Meeting System will open on the 13th of February for uploading profiles and sending meeting invites. The in-person meetings will be taking place on the 27th of February, while virtual meetings will take place on the 6th - 8th of March. For the virtual meetings, the system will allow you to have a secure audio/video call, as well as the option to present slides using a screen share function and we will have a dedicated room for in-person meetings.

PRESENTING OPPORTUNITIES:

Presentations are a popular and useful way to gain additional exposure with potential investors and pharma partners, which make up over half the audience. We are pleased to announce that once again we will have 20-minute and 10-minute presentations taking place in-person at the dedicated presenting tracks. Here you will be able to showcase your company in front of investors attending the physical event. The recording will be added to your company’s profile later, which will be available on demand for registered participants until the event portal closes. Start-up companies, which are looking for seed financing can apply for a Rising Stars – Seed Companies Session.

For those who are not able to present in-person, but are still interested to showcase their company, there is an option to purchase either a 20-minute or 10-minute presentation, which will be pre-recorded in advance and available to all registered attendees on the event’s portal. Start-up companies may also purchase a 5-minute pre-recorded showcase instead.

The Sachs Team can assist with the pre-recording of the presentation, or you can upload a video you already have. Interested viewers will be able to message or request a meeting with you using the Online Meeting System.

Confirmed Presenters Include:

EXHIBITING OPPORTUNITIES:

Make connections, engage in conversation, and exchange knowledge with key decision-makers eager to learn how your company can help them meet their goals and achieve their mission. Exhibiting at Sachs Spring Life Sciences Week is an effective way to gain leads, introduce new products and services, expand sales, and build relationships.

If you are attending the physical event, we have a limited number of tabletop exhibitions available at the venue, restricted to three companies. These exhibitions will be located in the 'Zurich A&B' room, where the registration, breaks, and the highest attendee traffic are concentrated.

For those who are not able to join the event or exhibit in-person, you could choose virtual exhibition package, which includes a dedicated virtual page, where we can upload your branded company’s profile and list ways to reach you, share video or images about services you provide and have files ready for download if you wish to share any additional information with potential clients.

If interested in learning more about exhibition options, please fill in the registration form.

SPONSORING OPPORTUNITIES:

There are a limited number of sponsorship opportunities for the forum, which include speaking, advertising, and branding options. Sponsors typically include investment banks and funds, large pharma, technology companies and service providers, including Stock Exchanges, IR companies, CROs, international lawyers and consulting companies. Tailored packages are available upon request. You can view the last event’s sponsors here.

To learn more about presenting, exhibition or sponsorship opportunities, please fill in registration form or contact us at [email protected] or by phone + 44 (0)203 463 4890.

Bronze Sponsor:

Sponsors in 2023:

---

Contributing Sponsor in 2023:

---

Supporters:

---

Financial, Advisory & Investors Attending:


AAA Family Office
AFK & Partners Asset Management LLC
Aliath Bioventures
Almeda Ventures
Amazon Web Services
Amplitude Ventures
Angelini Ventures S.p.A.
Apollo Health Ventures
ARVE Capital GmbH
Bank Julius Baer & Co. Ltd.
BlackRock
bmp Ventures AG
BOHE Angel Fund
Boostrap Europe
Boston Consulting Group
Breslin AG
Business Angels Switzerland
CARMA FUND Management GmbH
Cathay Health
Convergence Partners
DeBere Capital Partners
Debiopharm Innovation Fund SA
Debiopharm International S.A.
Digital Networks Plc. S.r.l.
Eliraz Ventures
Evoleen
Global Life Science Ventures GmbH
H Tree Capital
Hadean Ventures
HBM Partners AG
High-Tech Gründerfonds Management GmbH
imec.xpand
Innovestor Life Science Ltd.
IPF Partners
Johnston Associates, Inc.
JP Morgan
Kinled Holding Limited
Kurma Partners
Longliv Ventures
LSA Ventures
LSV Capital Partners
M2Care
Medicover AB
MEDKAP Investor Association
Mid Atlantic Bio Angels
MTIP AG
New Harbor Venture Partners, LLC
Panakès Partners SGR SpA
Pioneer Fund
Private Equity Investor
Rosetta Capital
Sanara Capital
TruVenturo GmbH
Versant Ventures
Vesalius Biocapital Partners Sàrl
VI Partners AG
Viopas Venture Consulting
Wellington Partners
XGEN Venture SGR S.p.A.

​To View All - Click Here